Latest news
Silence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:00:27 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMTVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 20:05:00 GMTState Street Corporation (VERA) discloses 4.1M-share stake in Vera Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 15:11:14 GMTEquity awards for Vera Therapeutics (VERA) Chief Regulatory Officer - Stock TitanStock Titan · Wed, 05 Aug 2026 20:14:31 GMTBlackRock (NYSE: BLK) discloses 5.34M-share Vera Therapeutics (VERA) stake - Stock TitanStock Titan · Thu, 30 Jul 2026 15:19:43 GMT